Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Plos One|March 21, 2023
Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world dataShannon L Reynolds, Harvey W Kaufman, William A Meyer, et al.
Vaccine|September 11, 2021
Vaccine exposure during pregnancy among privately and publicly insured women in the United States, 2016-2018Keran Moll, Hui-Lee Wong, Kathryn Fingar, et al.
Nature Medicine|July 9, 2002
Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cellsZoltan A Nagy, Bernd Hubner, Corinna Löhning, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2020
Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infectionRaymond A Harvey, Jeremy A Rassen, Carly A Kabelac, et al.
JAMA Internal Medicine|February 24, 2021
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future InfectionRaymond A Harvey, Jeremy A Rassen, Carly A Kabelac, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocketKent D Stewart, Jeffrey R Huth, Teresa I Ng, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinaseJames E Tarver, Theodore C Jessop, Marianne Carlsen, et al.
Pageof 4